AM Pharma
Developing treatments for severe medical conditions
Utrecht, Netherlands · $239.1M raised
- Headquarters
- Utrecht
- Employees
- 11–50
- Business Model
- B2B
- Website
- am-pharma.com
- Total Funding
- $239.1M
- Last Round
- $52.0M Extension RoundMar 2020
- Rounds
- 6
About
AM Pharma is a clinical-stage biotech developing ilofotase alfa and other therapeutics for severe medical conditions including acute kidney injury.
Summary
AM Pharma is a Biotech company based in Utrecht, Netherlands. It has raised $239.1M in total across 6 rounds, most recently a $52.0M Extension Round round in Mar 2020.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2020
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...